EPIVIDA
Rewriting the Code of Aging
EPIVIDA
Rewriting the Code of Aging
Rewriting the Code of Aging
Rewriting the Code of Aging
Age-related sarcopenia affects tens of millions of older adults worldwide and is a leading cause of frailty, loss of independence, falls, hospitalization, and mortality. Current approaches, including exercise, nutrition, and anabolic therapies, provide limited benefit and do not address the underlying epigenetic deterioration that drives age-related muscle decline.
Epivida is developing EPH-101, a first-in-class epigenetic therapeutic designed to restore youthful gene expression programs in skeletal muscle. Using the PNAfuse™ platform, EPH-101 activates endogenous regenerative pathways without altering genomic DNA sequence, with the goal of improving mitochondrial function, muscle strength, and tissue resilience.

At Epivida, we are pursuing a different approach.Our scientific thesis is that aging is fundamentally an epigenetic problem. Imagine your DNA as the complete instruction manual for a healthy, youthful cell. The information is still there throughout life. But over time, cellular stress and aging gradually obscure access to those instructions. The result is declining function, impaired recovery, and chronic disease. Our goal is to restore access to those youthful genetic programs safely, precisely, and selectively.
We love our customers, so feel free to visit during normal business hours.
4671 Commerce Center Drive, Plymouth, MI, USA
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Get 10% off your first purchase when you sign up for our newsletter!
Copyright © 2026 epividabio.com - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.